Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology, Clinical Diagnosis Track

Influence of acquisition duration, attenuation maps and scatter correction on halo artefacts in whole-body 68Ga-PSMA PET-MRI

Benjamin Noto, Katharina Auf der Springe, Nemanja Avramovic, Thomas Allkemper, Walter Heindel, Michael Schafers, Lars Stegger and Florian Buether
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 739;
Benjamin Noto
1Department of Nuclear Medicine University Hospital Muenster Muenster Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katharina Auf der Springe
2Department of Radiology University Hospital Muenster Muenster Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nemanja Avramovic
1Department of Nuclear Medicine University Hospital Muenster Muenster Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Allkemper
2Department of Radiology University Hospital Muenster Muenster Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Walter Heindel
2Department of Radiology University Hospital Muenster Muenster Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Schafers
1Department of Nuclear Medicine University Hospital Muenster Muenster Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lars Stegger
1Department of Nuclear Medicine University Hospital Muenster Muenster Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Florian Buether
1Department of Nuclear Medicine University Hospital Muenster Muenster Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

739

Objectives: While 68Ga-PSMA PET-MRI might be superior to PET-CT with regard to soft tissue assessment in prostate cancer evaluation, it is also known to potentially introduce additional PET image artefacts around high-activity structures ("halo artefacts") in current PET-MRI systems. We therefore investigated the impact of PET acquisition duration, attenuation data and scatter correction on halo artefact occurrence in current clinical whole-body PET/MRI.

Methods: Whole-body PET list mode data from twelve patients with prostate cancer were acquired one hour after injection of 2 MBq/kg [68Ga]HBED-CC-PSMA on a hybrid PET-MRI system (biograph mMR, Siemens Healthineers, with arms lying next to the body). List mode data were transformed into data sets representing 300s, 180s, 90s and 30s acquisition duration per bed position and were reconstructed without and with scatter correction using both relative and absolute scatter scaling, and additionally a correction for prompt gamma photons. MRI-derived attenuation maps were complemented by emission-based data in areas not covered by MRI (MLAA algorithm). A total of 264 image data sets representing different acquisition durations and attenuation/scatter/prompt gamma corrections were thus reconstructed. PET images were analysed regarding halo artefact occurrence according to the following scoring: 0: no distinct halo visible, 1: halo around either kidneys or bladder, 2: halo around both kidneys and bladder. Attenuation maps were analysed for successful MLAA-based arm completion.

Results: Halo artefacts were not present in non-scatter-corrected images. Decreasing PET acquisition durations resulted in significantly increased incidences of halo artefacts around kidneys and bladder for both relative scatter scaling and prompt gamma correction. Additionally, decreased lesion detectability and markedly lower arm attenuation values were seen. For relative scatter scaling, mean halo scores (± standard deviation) amounted to 0.50 ± 0.67, 0.67 ± 0.78, 1.67 ± 0.78, and 1.67 ± 0.67 for acquisition durations of 300s, 180s, 90s, 30s, respectively, proving a strong dependence of halo occurrences with scanning durations. Prompt gamma correction barely improved this to 0.50 ± 0.67, 0.67 ± 0.78, 1.67 ± 0.78, and 1.25 ± 0.62, respectively, although the areas affected by halos generally seemed smaller than without correction. Absolute scaling resulted in values of 1.42 ± 0.51, 1.42 ± 0.51, 1.42 ± 0.51, and 1.25 ± 0.45, respectively, demonstrating nearly duration-independent artefact occurrences. In case of relative scaling, emission data reconstructed with the 300s attenuation maps restored halo scores to the native 300s level for durations of 180s, 90s, and 30s, while reconstructing 300s emission data with attenuation data of 180s, 90s, and 30s led to halo scores of 0.67 ± 0.78, 1.67 ± 0.78, and 1.67 ± 0.67, respectively. Attenuation maps at 90s and 30s demonstrated markedly lower mean arm attenuation values (0.002 cm-1 at pelvic regions) than those at 300s (0.084 cm-1) and 180s (0.062 cm-1). Additionally, the mean volume of completed arms dropped in the pelvic bed position from 4.6 ± 1.2 L to 4.1 ± 1.3 L, 1.7 ± 0.7 L, and 2.1 ± 0.4 L for 300s, 180s, 90s, and 30s, respectively.

Conclusion: Short acquisition durations of less than 3 minutes per bed position result in unacceptable image artefacts in current clinical protocols of whole-body 68Ga-PSMA PET-MRI when using relative scatter scaling and should be avoided. Imperfections in MLAA-generated attenuation maps seem to be a paramount cause. On the other hand, neither prompt gamma correction nor absolute scaling obviate halo artefacts in the images, highlighting the need for more accurate scatter and attenuation correction methods for 68Ga-PSMA PET-MRI. Research Support: None

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 58, Issue supplement 1
May 1, 2017
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Influence of acquisition duration, attenuation maps and scatter correction on halo artefacts in whole-body 68Ga-PSMA PET-MRI
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Influence of acquisition duration, attenuation maps and scatter correction on halo artefacts in whole-body 68Ga-PSMA PET-MRI
Benjamin Noto, Katharina Auf der Springe, Nemanja Avramovic, Thomas Allkemper, Walter Heindel, Michael Schafers, Lars Stegger, Florian Buether
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 739;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Influence of acquisition duration, attenuation maps and scatter correction on halo artefacts in whole-body 68Ga-PSMA PET-MRI
Benjamin Noto, Katharina Auf der Springe, Nemanja Avramovic, Thomas Allkemper, Walter Heindel, Michael Schafers, Lars Stegger, Florian Buether
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 739;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology, Clinical Diagnosis Track

  • Immunohistochemical analysis of Gastrin-Releasing-Peptide receptor (GRPr) and Prostate-Specific- Membrane Antigen (PSMA) in primary prostate cancer: comparison with radiolabeled GRPr antagonist (68Ga-RM2) PET/CT
  • Relationship between FDG PETCT imaging and CA 125 levels in treated patients with Ovarian cancers - Can FDG PETCT define and predict the disease burden in clinically suspected recurrence ?
  • Cancer-associated fibroblasts enhance tumor 18F-FDG uptake and contribute to the intratumor heterogeneity of SUVmax
Show more Oncology, Clinical Diagnosis Track

Prostate III: PSMA Imaging

  • Late 68Ga-PSMA PET-scans improve lesion detectability in prostate cancer patients with biochemical relapse
  • Cold Kit PSMA Imaging: First In-Man Study of 68Ga-THP-PSMA PET/CT in Patients with Prostate Cancer
  • Comparison of a novel fluorine-18 labeled PSMA-targeting agent, CTT1057, to gallium-68 PSMA-11 in patients with prostate cancer
Show more Prostate III: PSMA Imaging

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire